Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boulder/denver blog main
detroit blog main
indiana blog main
2
×
national
2
×
national blog main
national top stories
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
seattle blog main
startups
texas blog main
texas top stories
venture capital
wisconsin blog main
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
biotech
bluegrass vascular
boston top stories
boulder/denver top stories
brainvectis
bret piatt
c. greg guyer
cancer
cara therapeutics
china
cognitive scale
dallas
dave copps
deerfield management
detroit top stories
What
developing
2
×
activity
approvals
bio
biogen
business
clamped
comes
company
control
covid
delays
economic
effect
execs
external
factors
fast
fda
founders
immigration
including
innovation
investors
ipo
isn’t
leaders
lot
medicines
new
oric’s
promoting
roundup
showing
spread
talk
taxes
testing
trump
work
Language
unset
Current search:
national
×
developing
×
" indiana blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation